A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.
Also called NCT07215312
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07215312
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07215312. Randomized; no masking; primary purpose treatment. Start 2025-10-13 (actual); primary completion 2026-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- LY3938577
- Intervention (Drug)
- Degludec
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct07215312- Content hash
54262671e6272268d151e04d118bcbb99bcf2f11d72cb298e4bf266268804511